Concepedia

Masumi Suzui

MS

Statistics

Publications

63

Citations

4.5K

H-Index

32

Active since

1993

Affiliations

Gifu University(Current)

Nagoya City University

University of the Ryukyus

Columbia University

National Institute of Health Sciences

Masumi Suzui is an author at Gifu University specializing in medicine, oncology, and pharmacology.

Publications per year

1993–2023

63

Publications

63

Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines.

Andrew K. Joe, Hui Liu, Masumi Suzui et al. · PubMed · 2002 · 455 citations

Medicine, Oncology, Pharmacology +14

Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.

Muneyuki Masuda, Masumi Suzui, Ryuji Yasumatu et al. · PubMed · 2002 · 379 citations

Life Sciences, Molecular Biology, Oncology +15

Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids

Takuji Tanaka, Toshihiro Kojima, Toshihiko Kawamori et al. · Carcinogenesis · 1993 · 335 citations

Medicine, Oral Pathology, Pharmacology +13

Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.

Muneyuki Masuda, Masumi Suzui, I. Bernard Weinstein · PubMed · 2001 · 319 citations

Medicine, Oncology, Pharmacology +13

Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction

Muneyuki Masuda, Masumi Suzui, Jin T. E. Lim et al. · Journal of Experimental Therapeutics and Oncology · 2002 · 233 citations

Medicine, Oncology, Pharmacology +16

1–5 of 63